Collegium Pharmaceutical, Inc. COLL Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s accounts payable?
- Collegium Pharmaceutical, Inc. (COLL) reported accounts payable of $6.83M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s accounts payable changed year-over-year?
- Collegium Pharmaceutical, Inc.'s accounts payable decreased by 61.8% year-over-year, from $17.85M to $6.83M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s accounts payable has grown at a 1.3% compound annual growth rate (CAGR), from $10.02M to $10.66M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.